Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
3.53M
-
Shares change
-
-1.04M
-
Total reported value, excl. options
-
$32.7M
-
Value change
-
-$14.2M
-
Put/Call ratio
-
1
-
Number of buys
-
3
-
Number of sells
-
-27
-
Price
-
$9.27
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q1 2024
34 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q1 2024.
Pulmonx Corp - COMMON STOCK (LUNG) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.53M shares
of 40.4M outstanding shares and own 8.75% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (2.65M shares), DEUTSCHE BANK AG\ (521K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (301K shares), JPMORGAN CHASE & CO (265K shares), NORGES BANK (151K shares), Bank of New York Mellon Corp (140K shares), CITADEL ADVISORS LLC (133K shares), Legal & General Group Plc (24.8K shares), Voya Investment Management LLC (12.2K shares), and Royal Bank of Canada (2.99K shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.